Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
PUBLIC HEALTH / CLINICAL RESEARCH
Visual impairment and frailty: insights from genetic correlation and Mendelian randomization
1
Chengdu Integrated Traditional Chinese Medicine and Western Medicine Hospital, Chengdu, China
2
Chengdu University of Traditional Chinese Medicine, Chengdu, China
Submission date: 2024-07-30
Final revision date: 2025-01-22
Acceptance date: 2025-02-04
Online publication date: 2025-04-20
Corresponding author
Tianshu Hou
Chengdu Integrated Traditional Chinese Medicine and Western Medicine Hospital Chengdu, China
Chengdu Integrated Traditional Chinese Medicine and Western Medicine Hospital Chengdu, China
KEYWORDS
visual impairmentfrailtyMendelian randomizationcausal relationshiplinkage disequilibrium score regression
TOPICS
ABSTRACT
Introduction:
Visual impairment (VI) is associated with frailty in observational studies, but whether this relationship is causal remains uncertain. This study aimed to investigate the genetic correlation and causal associations between genetically predicted VI and frailty using Mendelian randomization (MR) and linkage disequilibrium score regression (LDSC).
Material and methods:
Genome-wide association studies provided summary data for VI subtypes (glaucoma, cataracts, diabetic retinopathy, age-related macular degeneration, hypermetropia, myopia) and frailty measures (frailty index (FI) and fried frailty score (FFS)). LDSC was used to estimate genetic correlations, and MR was conducted using inverse-variance weighted (IVW) as the primary method, supplemented by MR-Egger and weighted median. Sensitivity analyses, including radial MR, Cochran’s Q test, MR-Egger intercept, and MR-PRESSO, were used to assess pleiotropy and heterogeneity.
Results:
Significant genetic correlations were found between VI, cataracts, age-related macular degeneration, and frailty. Suggestive correlations were identified between myopia and FI. MR analysis showed increased FI and FFS risks with other cataracts (FI: p = 0.0324; FFS: p = 0.027) and diabetic retinopathy (FI: p < 0.001; FFS: p = 0.0119). Visual disturbances were associated with increased FI risk (p = 0.0101), while age-related macular degeneration elevated FFS risk (p = 0.0251). Reverse analysis revealed that frailty also increased susceptibility to VI. No causal relationships were found for other eye diseases, and analyses showed no evidence of pleiotropy or heterogeneity.
Conclusions:
This study highlights significant genetic associations and bidirectional causal relationships between VI and frailty. Future research should include multiethnic populations and larger datasets to further explore these mechanisms.
Visual impairment (VI) is associated with frailty in observational studies, but whether this relationship is causal remains uncertain. This study aimed to investigate the genetic correlation and causal associations between genetically predicted VI and frailty using Mendelian randomization (MR) and linkage disequilibrium score regression (LDSC).
Material and methods:
Genome-wide association studies provided summary data for VI subtypes (glaucoma, cataracts, diabetic retinopathy, age-related macular degeneration, hypermetropia, myopia) and frailty measures (frailty index (FI) and fried frailty score (FFS)). LDSC was used to estimate genetic correlations, and MR was conducted using inverse-variance weighted (IVW) as the primary method, supplemented by MR-Egger and weighted median. Sensitivity analyses, including radial MR, Cochran’s Q test, MR-Egger intercept, and MR-PRESSO, were used to assess pleiotropy and heterogeneity.
Results:
Significant genetic correlations were found between VI, cataracts, age-related macular degeneration, and frailty. Suggestive correlations were identified between myopia and FI. MR analysis showed increased FI and FFS risks with other cataracts (FI: p = 0.0324; FFS: p = 0.027) and diabetic retinopathy (FI: p < 0.001; FFS: p = 0.0119). Visual disturbances were associated with increased FI risk (p = 0.0101), while age-related macular degeneration elevated FFS risk (p = 0.0251). Reverse analysis revealed that frailty also increased susceptibility to VI. No causal relationships were found for other eye diseases, and analyses showed no evidence of pleiotropy or heterogeneity.
Conclusions:
This study highlights significant genetic associations and bidirectional causal relationships between VI and frailty. Future research should include multiethnic populations and larger datasets to further explore these mechanisms.
REFERENCES (50)
1.
Gonzales-Turín JM, Rodríguez-Laso Á, Carnicero JA, García-García FJ, Rodríguez-Mañas L. Relationship between self-reported visual impairment and worsening frailty transition states in older people: a longitudinal study. Aging Clin Exp Res 2021; 33: 2491-8.
2.
Swenor BK, Simonsick EM, Ferrucci L, et al. Visual impairment and incident mobility limitations: the health, aging and body composition study. J Am Geriatr Soc 2015; 63: 46-54.
3.
Swenor BK, Muñoz B, West SK. A longitudinal study of the association between visual impairment and mobility performance in older adults: the salisbury eye evaluation study. Am J Epidemiol 2014; 179: 313-22.
4.
Ong SY, Ikram MK, Haaland BA, et al. Myopia and cognitive dysfunction: the singapore malay eye study. Invest Ophthalmol Vis Sci 2013; 54: 799-803.
5.
Christ SL, Zheng DD, Swenor BK, et al. Longitudinal relationships among visual acuity, daily functional status, and mortality: the Salisbury Eye Evaluation Study. JAMA Ophthalmol 2014; 132: 1400-6.
6.
Swenor BK, Lee MJ, Tian J, Varadaraj V, Bandeen-Roche K. Visual Impairment and frailty: examining an understudied relationship. J Gerontol A Biol Sci Med Sci 2020; 75: 596-602.
7.
Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health 2017; 5: e1221-34.
8.
Xue QL. The frailty syndrome: definition and natural history. Clin Geriatr Med 2011; 27: 1-15.
9.
Lan X, Li H, Wang Z, Chen Y. Frailty as a predictor of future falls in hospitalized patients: a systematic review and meta-analysis. Geriatr Nurs 2020; 41: 69-74.
10.
Yamada M, Arai H. Social frailty predicts incident disability and mortality among community-dwelling Japanese older adults. J Am Med Dir Assoc 2018; 19: 1099-103.
11.
Chang SF, Lin HC, Cheng CL. The relationship of frailty and hospitalization among older people: evidence from a meta-analysis. J Nurs Scholarsh 2018; 50: 383-91.
12.
O’Caoimh R, Sezgin D, O’Donovan MR, et al. Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. Age Ageing 2021; 50: 96-104.
13.
Chi J, Chen F, Zhang J, et al. Impacts of frailty on health care costs among community-dwelling older adults: a meta-analysis of cohort studies. Arch Gerontol Geriatr 2021; 94: 104344.
14.
Klein BE, Klein R, Knudtson MD, Lee KE. Relationship of measures of frailty to visual function: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2003; 101: 191-6.
15.
Liljas AEM, Carvalho LA, Papachristou E, et al. Self-reported vision impairment and incident prefrailty and frailty in English community-dwelling older adults: findings from a 4-year follow-up study. J Epidemiol Community Health 2017; 71: 1053-8.
16.
Varadaraj V, Lee MJ, Tian J, et al. Near vision impairment and frailty: evidence of an association. Am J Ophthalmol 2019; 208: 234-41.
17.
Amir NN, Kamaruzzaman SB, Effendi-Tenang I, et al. Contrast sensitivity is associated with frailty. Eur Geriatr Med 2021; 12: 313-9.
18.
Soler V, Sourdet S, Balardy L, et al. Visual impairment screening at the geriatric frailty clinic for assessment of frailty and prevention of disability at the Gérontopôle. J Nutr Health Aging 2016; 20: 870-7.
19.
Bulik-Sullivan B, Finucane HK, Anttila V, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet 2015; 47: 1236-41.
20.
Zhou J, Li Y, Lin Y, et al. The genetic causal association between hip or knee osteoarthritis and frailty: a two-sample Mendelian randomization analysis. Arch Med Sci 2024; 20: 938-46.
21.
Sekula P, Del Greco MF, Pattaro C, Köttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol 2016; 27: 3253-65.
22.
Davey Smith G, Holmes MV, Davies NM, Ebrahim S. Mendel’s laws, Mendelian randomization and causal inference in observational data: substantive and nomenclatural issues. Eur J Epidemiol 2020; 35: 99-111.
23.
Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA 2021; 326: 1614-21.
24.
Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014; 23: R89-98.
25.
Lawlor DA. Commentary: two-sample Mendelian randomization: opportunities and challenges. Int J Epidemiol 2016; 45: 908-15.
26.
Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 2023; 613: 508-18.
27.
Atkins JL, Jylhävä J, Pedersen NL, et al. A genome-wide association study of the frailty index highlights brain pathways in ageing. Aging Cell 2021; 20: e13459.
28.
Ye Y, Noche RB, Szejko N, et al. A genome-wide association study of frailty identifies significant genetic correlation with neuropsychiatric, cardiovascular, and inflammation pathways. Geroscience 2023; 45: 2511-23.
29.
Hoogendijk EO, Afilalo J, Ensrud KE, et al. Frailty: implications for clinical practice and public health. Lancet 2019; 394: 1365-75.
30.
Goławski M, Lejawa M, Banach M, et al. Association between Lp(a) and T2D: a Mendelian randomization study. Arch Med Sci 2024; 20: 1002-5.
31.
Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol 2011; 40: 740-52.
32.
Burgess S, Davey Smith G, Davies NM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res 2019; 4: 186.
33.
Greco MF, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med 2015; 34: 2926-40.
34.
Bowden J, Del Greco MF, Minelli C, et al. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 2017; 36: 1783-802.
35.
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015; 44: 512-25.
36.
Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50: 693-8.
37.
Bowden J, Spiller W, Del Greco MF, et al. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int J Epidemiol 2018; 47: 2100.
38.
Bowden J, Del Greco MF, Minelli C, et al. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol 2019; 48: 728-42.
39.
Ni G, Moser G, Wray NR, Lee SH. Estimation of genetic correlation via linkage disequilibrium score regression and genomic restricted maximum likelihood. Am J Hum Genet 2018; 102: 1185-94.
40.
Bulik-Sullivan BK, Loh PR, Finucane HK, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet 2015; 47: 291-5.
41.
Carter CS, Hofer T, Seo AY, Leeuwenburgh C. Molecular mechanisms of life- and health-span extension: role of calorie restriction and exercise intervention. Appl Physiol Nutr Metab 2007; 32: 954-66.
42.
Masuda T, Shimazawa M, Hara H. Retinal diseases associated with oxidative stress and the effects of a free radical scavenger (Edaravone). Oxid Med Cell Longev 2017; 2017: 9208489.
43.
Pinazo-Durán MD, Gallego-Pinazo R, García-Medina JJ, et al. Oxidative stress and its downstream signaling in aging eyes. Clin Interv Aging 2014; 9: 637-52.
44.
Kong GY, Van Bergen NJ, Trounce IA, Crowston JG. Mitochondrial dysfunction and glaucoma. J Glaucoma 2009; 18: 93-100.
45.
Smith L, López-Sánchez GF, Jacob L, et al. Objectively measured far vision impairment and sarcopenia among adults aged ≥ 65 years from six low- and middle-income countries. Aging Clin Exp Res 2021; 33: 2995-3003.
46.
Ho VWT, Chen C, Merchant RA. Cumulative effect of visual impairment, multimorbidity, and frailty on intrinsic capacity in community-dwelling older adults. J Aging Health 2020; 32: 670-6.
47.
Laudisio A, Navarini L, Margiotta DPE, et al. The association of olfactory dysfunction, frailty, and mortality is mediated by inflammation: results from the InCHIANTI study. J Immunol Res 2019; 2019: 3128231.
48.
Liljas AE, Wannamethee SG, Whincup PH, et al. Socio-demographic characteristics, lifestyle factors and burden of morbidity associated with self-reported hearing and vision impairments in older British community-dwelling men: a cross-sectional study. J Public Health 2016; 38: e21-8.
49.
Dai Z, Wu Y, Chen J, Huang S, Zheng H. Assessment of relationships between frailty and chronic pain: a bidirectional two-sample Mendelian randomisation study. Age Ageing 2024; 53: afad256.
50.
Xin M, Wang W, Zhou M, et al. Genetically-predicted effects of lifestyle factors on frailty: evidence from Mendelian randomization study. Arch Gerontol Geriatr 2025; 129: 105662.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
